In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response

Nature Medicine

Volumn 16, Issue 6, 2010, Pages 718-722

  Fan, Zhigang ^a   Spencer, Joel A ^b,c   Lu, Yan ^a   Pitsillides, Costas M ^b,d   Singh, Gurbakhshish ^a   Kim, Pilhan ^b   Yun, Seok H ^b   Toxavidis, Vasilis ^a   Strom, Terry B ^a   Lin, Charles P ^b   Koulmanda, Maria ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Tufts University   (United States)

^d Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; RAPAMYCIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNE RESPONSE; IN VIVO STUDY; KIDNEY CAPSULE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; COLOR; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

MUS;

EID: 77953232399     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2155     Document Type: Article

References (29)

1. Edinger, M. et al. Evaluation of effector cell fate and function by in vivo bioluminescence imaging. Methods 31, 172-179 (2003).
2. Medarova, Z. et al. In vivo imaging of a diabetogenic CD8+ T cell response during type 1 diabetes progression. Magn. Reson. Med. 59, 712-720 (2008).
3. Toso, C. et al. Assessment of 18F-FDG-leukocyte imaging to monitor rejection after pancreatic islet transplantation. Transplant. Proc. 38, 3033-3034 (2006).
4. Wu, Y.L. et al. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc. Natl. Acad. Sci. USA 103, 1852-1857 (2006).
5. Novak, J. et al. In vivo fow cytometer for real-time detection and quantifcation of circulating cells. Opt. Lett. 29, 77-79 (2004).
6. Kim, P. et al. In vivo confocal and multiphoton microendoscopy. J. Biomed. Opt. 13, 010501 (2008).
7. Koulmanda, M. et al. Curative and beta cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl. Acad. Sci. USA 105, 16242-16247 (2008).
8. Koulmanda, M. et al. Modifcation of adverse infammation is required to cure new-onset type 1 diabetic hosts. Proc. Natl. Acad. Sci. USA 104, 13074-13079 (2007).
9. Tran, H.M. et al. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J. Immunol. 159, 2232-2239 (1997).
10. Sánchez-Fueyo, A. et al. Tim-3 inhibits T helper type 1-mediated auto-and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4, 1093-1101 (2003).
11. Strom, T.B. Is transplantation tolerable? J. Clin. Invest. 113, 1681-1683 (2004).
12. Strom, T.B. et al. The TH1/TH2 paradigm and the allograft response. Curr. Opin. Immunol. 8, 688-693 (1996).
13. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
14. Korn, T. et al. IL-21 initiates an alternative pathway to induce proinfammatory TH17 cells. Nature 448, 484-487 (2007).
15. Gao, W. et al. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specifc regulatory T cells. Am. J. Transplant. 7, 1722-1732 (2007).
16. Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
17. Wan, Y.Y. & Flavell, R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102, 5126-5131 (2005).
18. Zhong, X. et al. Reciprocal generation of TH1/TH17 and Treg cells by B1 and B2 B cells. Eur. J. Immunol. 37, 2400-2404 (2007).
19. Fontenot, J.D. et al. Regulatory T cell lineage specifcation by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
20. Joffre, O. et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14, 88-92 (2008).
21. Lechler, R.I. et al. Organ transplantation\how much of the promise has been realized? Nat. Med. 11, 605-613 (2005).
22. Li, Y. et al. Blocking both signal 1 and signal 2 of T cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med. 5, 1298-1302 (1999).
23. Wells, A.D. et al. Requirement for T cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5, 1303-1307 (1999).
24. Kamradt, T. & Mitchison, N.A. Tolerance and autoimmunity. N. Engl. J. Med. 344, 655-664 (2001).
25. Zheng, X.X. et al. The balance of deletion and regulation in allograft tolerance. Immunol. Rev. 196, 75-84 (2003).
26. Zheng, X.X. et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19, 503-514 (2003).
27. Vintersten, K. et al. Mouse in red: red fuorescent protein expression in mouse ES cells, embryos and adult animals. Genesis 40, 241-246 (2004).
28. Shen, F.W. et al. Cloning of Ly-5 cDNA. Proc. Natl. Acad. Sci. USA 82, 7360-7363 (1985).
29. Veilleux, I., Spencer, J.A., Biss, D.P., Côté, D. & Lin, C.P. In vivo cell tracking with video rate multimodality laser scanning microscopy. IEEE J. Sel. Top. Quantum Electron. 14, 10-18 (2008).